Media News

FAIRFIELD, N.J., April 22, 2022 /PRNewswire/ -- Vela Diagnostics has announced that its ViroKey® SARS-CoV-2 RT-PCR Test v2.0 now has the additional capability to be used for pooling, using a three-in-one media pooling strategy. This FDA EUA authorized indication is authorized for use in laboratories certified under CLIA to perform high complexity tests, for the qualitative detection of RNA from...

JAKARTA, Indonesia, April 22, 2022 /PRNewswire/ -- In an attempt to achieve the company's ultimate goal to have zero environmental impact, Novo Nordisk Indonesia has initiated various activities, including switching the company's delivery method from air freight to sea freight and launching an internal campaign called "Plastic Funtastic: Turning Your Plastic Waste into Something Fantastic". Novo Nordisk Indonesia...

GUANGZHOU, China, April 22, 2022 /PRNewswire/ -- The 10-day 131st Canton Fair kicked off online on April 15. The Health and Recreation section, among a wide range of exhibits, draws the attention of global buyers. Over 260,000 exhibits were displayed online by nearly 3,600 enterprises in the section, ranging from food,  medicine and health products, medical machinery, to sports,...

Results from the trial present a significant advancement for patients dealing with previously untreated IDH1-mutated AML Global Phase 3 trial of TIBSOVO (ivosidenib tablets) met its primary endpoint of event-free survival and all key secondary endpoints, complete remission rate, overall survival, complete remission and complete remission with partial hematologic recovery rate and objective response rate SUZHOU, China,...

HANGZHOU, China, April 22, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that its Class I innovative drug LNK01004, has been approved by National Medical Products Administration (NMPA) for clinical trials for the treatment of psoriasis. LNK01004 is a novel kinase inhibitor that can simultaneously inhibit multiple inflammatory...

MELBOURNE, Australia and LIÈGE, Belgium, April 22, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces agreements with Sociedade Avanço, Unipessoal, LDA (Avanço) and THP Medical Products Vertriebs GmbH (THP) for the distribution of Telix's prostate cancer investigational imaging product Illuccix® (Kit for the preparation of gallium-68 (68Ga) gozetotide (also...

An international survey of people in the United States, the United Kingdom, Italy, and the Gulf reveals widespread confusion around health requirements for air travel, and fears that the aviation sector is not prepared for another global health crisis Many people in every country surveyed say they chose not to fly in 2021 because of Covid-related requirements 46%...

Terran to advance the development of two of Sanofi's Phase 3 CNS therapeutics Transaction includes worldwide exclusive rights for development and commercialization in all fields of use NEW YORK, April 21, 2022 /PRNewswire/ -- Terran Biosciences, Inc. ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics...

Lunit gets greenlight to accelerate listing on the KOSDAQ market First Korean healthcare company to receive "AA-AA" ratings in technology assessment SEOUL, South Korea, April 21, 2022 /PRNewswire/ -- Lunit, a leading medical AI provider, announced today a preliminary approval from the Korea Exchange for initial public offering (IPO) on the...

XI'AN, China, April 21, 2022 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has successfully developed new nutraceutical compounds – Glucoraphanin ("GF") and Sulforaphane ("SFN"), both of which are compounds extracted from cruciferous vegetables that could...